May 17th 2022
The booster is given at least five months after completion of a primary series.
May 17th 2022
The FDA emergency use authorization allows the nonprescription test to use at-home sample collection with testing performed in a laboratory.
May 17th 2022
FDA regulators said the data to support the EUA, which was submitted by a physician, is not sufficient to support the use of the antidepressant fluvoxamine for the treatment of patients with COVID-19.
May 16th 2022
The role of health economic and real-world evidence has become, and will continue to be, an important aspect of healthcare decision-making.
May 16th 2022
Mounjaro is a first-in-class medicine that activates both the GLP-1 and GIP receptors, which leads to improved blood sugar control.